Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer

Nir Peled(Tel Aviv University), Vincent A. Miller(Foundation Medicine (United States))

Journal of Thoracic Oncology

August 15, 2012

10.1097/jto.0b013e3182614ab5

Cited by 132

Related Papers

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database

|JAMA|2019|560

Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer

|The Oncologist|2015|146